Lymph node ratio is a prognostic predictor for patients with papillary thyroid carcinoma and lateral lymph node metastasis-the result of a retrospective cohort study at a single-center with long-term follow-up time

Author:

Huang Hui1,Liu Yunhe1,Liu Wensheng1,Ni Song1,Liu Shaoyan1

Affiliation:

1. Cancer Hospital of Chinese Academy of Medical Sciences

Abstract

Abstract Background Lymph node metastases (LNMs) are common in papillary thyroid carcinoma (PTC). The lymph node ratio (LNR) is suggested as a prognostic factor in many cancers. We aimed to evaluate the prognostic value of the LNR in PTC with lateral LNM. Methods This retrospective study reviewed the medical records of patients with PTC who underwent initial surgery in our institution from January 2000 to December 2012. The association of LNR and DSS was assessed using a Cox proportional hazards model with restricted cubic spline (RCS). Univariate and multivariate analyses were performed using Cox regression analysis to assess the factors predicting disease-specific survival (DSS). Results A total of 1036 patients with PTC were analyzed. After a median (range) follow-up of 90 (12–258) months, 45 patients died, 23 of whom died from thyroid cancer. The 10-year DSS for all study patients were 95.8%. Based on RCS curve analysis, a cutoff of 0.25 was selected for the LNR. A total of 587 (56.7%) patients had an LNR ≤ 0.25, and 449 (43.3%) patents had an LNR > 0.25. The 10-year DSS rates for patients with LNR ≤ 0.25 and > 0.25were 96.6% and 94.8%, respectively. Multivariate Cox regression analysis revealed that age group (HR, 9.13; 95% CI, 3.58–23.31, P < 0.001) and LNR (HR, 2.99; 95% CI, 1.22–7.33, P = 0.017) were independent predictors of DSS. Conclusion The results showed that an LNR greater than 0.25 was independently associated with an adverse DSS. LNR is a reliable predictor of both DSS of patients with PTC and lateral LNM.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3